ホーム › 食道腺癌 › カリフォルニア州

カリフォルニア州における食道腺癌の臨床試験

カリフォルニア州内の拠点で、食道腺癌に関する22件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト（英語）

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

City of Hope, Duarte
Hoag Memorial Hospital Presbyterian, Newport Beach

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/05更新 · NCT07544589

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Kaiser Permanente-Anaheim, Anaheim
Kaiser Permanente-Baldwin Park, Baldwin Park
Kaiser Permanente-Bellflower, Bellflower
他37件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/10/05更新 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Kaiser Permanente-Deer Valley Medical Center, Antioch
PCR Oncology, Arroyo Grande
Sutter Auburn Faith Hospital, Auburn
他61件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05677490

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
Ronald Reagan UCLA Medical Center, Los Angeles
他3件

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

USC/Norris Comprehensive Cancer Center, Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Local Institution - 0428, San Francisco

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Oncology Institute of Hope and Innovation, Cerritos
Ellison Medical Institute, Los Angeles
Valkyrie Clinical Trials, Los Angeles
他3件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

UCLA Hematology/Oncology - Atascadero, Atascadero
UCLA Hematology/Oncology - Burbank, Burbank
UCLA Hematology/Oncology - Encino, Encino
他5件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07392892

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Duarte, Duarte
Providence Medical Foundation, Santa Rosa

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413

Lucid Registry Study

LUCID DX, Lake Forest

被験者募集中観察研究

全年齢 · 全性別 · 2026/09/28更新 · NCT05965999

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

University of California, Los Angeles, Los Angeles
Kaiser Permanente Oakland Medical Center, Oakland
Kaiser Permanente, San Jose

被験者募集中

18歳〜89歳 · 全性別 · 2026/09/11更新 · NCT05753748

A Study of KK2269 in Adult Participants With Solid Tumors

City Of Hope National Medical Center, Duarte
Hoag Memorial Hospital Presbyterian, Newport Beach

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/10更新 · NCT06266299

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Duarte
Research Site, Fountain Valley
Research Site, Fullerton
他5件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

University of California, San Francisco, San Francisco
John Muir Medical Center-Walnut Creek, Walnut Creek

被験者募集中

18歳以上 · 全性別 · 2026/08/14更新 · NCT04221893

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Los Angeles Cancer Network, Los Angeles
Pih Health Hematology Medical Oncology, Whittier

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

City of Hope, Duarte

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

被験者募集中早期第1相

18歳以上 · 全性別 · 2026/07/07更新 · NCT06824363

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Providence Medical Foundation, Anaheim
Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
他7件

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632